Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Required transition from research to clinical application: Report on the 4D treatment planning workshops 2014 and 2015.
Knopf AC, Stützer K, Richter C, Rucinski A, da Silva J, Phillips J, Engelsman M, Shimizu S, Werner R, Jakobi A, Göksel O, Zhang Y, Oshea T, Fast M, Perrin R, Bert C, Rinaldi I, Korevaar E, McClelland J. Knopf AC, et al. Among authors: stutzer k. Phys Med. 2016 Jul;32(7):874-82. doi: 10.1016/j.ejmp.2016.05.064. Epub 2016 Jun 18. Phys Med. 2016. PMID: 27328991
Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability Analysis.
Jakobi A, Bandurska-Luque A, Stützer K, Haase R, Löck S, Wack LJ, Mönnich D, Thorwarth D, Perez D, Lühr A, Zips D, Krause M, Baumann M, Perrin R, Richter C. Jakobi A, et al. Among authors: stutzer k. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1165-1174. doi: 10.1016/j.ijrobp.2015.04.031. Epub 2015 Apr 23. Int J Radiat Oncol Biol Phys. 2015. PMID: 26194685
NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A, Stützer K, Bandurska-Luque A, Löck S, Haase R, Wack LJ, Mönnich D, Thorwarth D, Perez D, Lühr A, Zips D, Krause M, Baumann M, Perrin R, Richter C. Jakobi A, et al. Among authors: stutzer k. Acta Oncol. 2015;54(9):1658-64. doi: 10.3109/0284186X.2015.1071920. Epub 2015 Sep 4. Acta Oncol. 2015. PMID: 26340301
Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure.
Zschaeck S, Haase R, Abolmaali N, Perrin R, Stützer K, Appold S, Steinbach J, Kotzerke J, Zips D, Richter C, Gudziol V, Krause M, Zöphel K, Baumann M. Zschaeck S, et al. Among authors: stutzer k. Acta Oncol. 2015;54(9):1355-63. doi: 10.3109/0284186X.2015.1074720. Epub 2015 Sep 23. Acta Oncol. 2015. PMID: 26398663 Clinical Trial.
PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial.
Zschaeck S, Simon M, Löck S, Troost EG, Stützer K, Wohlfahrt P, Appold S, Makocki S, Bütof R, Richter C, Baumann M, Krause M. Zschaeck S, et al. Among authors: stutzer k. Trials. 2016 Nov 15;17(1):543. doi: 10.1186/s13063-016-1679-4. Trials. 2016. PMID: 27846903 Free PMC article. Clinical Trial.
39 results